Scientists have discovered a method for creating renewable cancer-killing T cells in laboratory conditions, which could be used directly in patients for cancer treatments. T cell therapies currently use a patient’s own T cells, but this costs lots of time and money to do. That’s why this scientific breakthrough is so important: it potentially makes immunotherapies cheaper and more widely available.